Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HCW Biologics (HCWB) Return on Sales (2022 - 2025)

HCW Biologics (HCWB) has disclosed Return on Sales for 4 consecutive years, with 220.45% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales fell 21128.0% year-over-year to 220.45%, compared with a TTM value of 30.18% through Sep 2025, down 1946.0%, and an annual FY2024 reading of 11.73%, down 258.0% over the prior year.
  • Return on Sales was 220.45% for Q3 2025 at HCW Biologics, up from 560.53% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.6% in Q1 2022 and bottomed at 560.53% in Q2 2025.
  • Average Return on Sales over 4 years is 95.7%, with a median of 8.13% recorded in 2023.
  • The sharpest move saw Return on Sales skyrocketed 12357bps in 2024, then crashed -53581bps in 2025.
  • Year by year, Return on Sales stood at 4.29% in 2022, then tumbled by -89bps to 8.13% in 2023, then fell by -6bps to 8.62% in 2024, then tumbled by -2458bps to 220.45% in 2025.
  • Business Quant data shows Return on Sales for HCWB at 220.45% in Q3 2025, 560.53% in Q2 2025, and 438.62% in Q1 2025.